This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Breast Cancer Diagnostics Market

Breast Cancer Diagnostics Market

Breast Cancer Diagnostics Market By Test Type (CA Tests, BRCA Test, ER & PR Test, CEA Test, KRAS Test), By End-use (Hospital Associated Labs, Independent Diagnostic Laboratories, Cancer Research Institutes) & Region - Forecast to 2021-2031

Breast Cancer Diagnostics Market
  • Oct-2021
  • List of Tables : 185
  • List of Figures : 69
  • 170 Pages
  • Healthcare

Market Snapshot

A recently revised survey on the breast cancer diagnostics market by Fact.MR predicts demand to rise at a healthy CAGR of around 7% over the decade. The survey also states that, the global breast cancer diagnostics market was valued at around US$ 4 Bn in 2020, and is slated to expand almost 2X by 2031.

Global Market CAGR (2021-2031) 7%
North America Revenue Share (2020) 45%
Global Market Value (2020) US$ 4 Bn
Hospital-associated Labs Market Share (2020) 50%

Demand Analysis of Breast Cancer Diagnostics from 2016-2020 Vs Market Projections for 2021-2031

The number of breast cancer cases across the globe is rising rapidly and has become the most common type of cancer in 2021. Breast cancer diagnostics market revenue in 2020 was worth around US$ 4 Bn, and demand for diagnosis is expected to increase exponentially over the decade.

Early detection of breast cancer tumors is one of the major challenges in diagnosis and treatment, as in most cases, they are detected after they have grown to an advanced stage.

Demand for early detection of breast cancer is seeing a major rise as people are seeking more efficient diagnostic solutions to deal with the disease effectively. Apart from other tests to detect breast cancer, imaging and screening have also seen substantial rise in popularity. Screening for breast cancer is deemed effective, but some methods are still being debated whether they are safe and accurate for prolonged use.

Breast cancer diagnostic PCR tests, biopsy for breast cancer diagnostics, and application of microarray in breast cancer diagnostics are some of the trends that are expected to be witnessed over the decade.

As per Fact.MR, a market research and competitive intelligence provider, the global breast cancer diagnostics industry is anticipated to evolve at a healthy CAGR of around 7% over through 2031.

What Other Diagnostic Trends are Prevalent in the Marketplace?

As research on the detection of breast cancer increases, new and innovative diagnostic methods are being adopted and applied. Most of these methods are not used extensively, but as research is backing their credibility, we expect these methods to become mainstream over the years.

  • Diagnostic Imaging for Breast Cancer
  • Biopsy Procedure for Breast Cancer Diagnostics
  • Genomic Tests for Breast Cancer Diagnostics
  • Blood Tests for Breast Cancer Diagnostics
  • Next-generation Sequencing for Breast Cancer Diagnostics
  • Microarrays in breast cancer diagnostics

Imaging is the most prominent and widely used among these. Demand for genomic tests in breast cancer diagnostics, demand for next-generation sequencing in breast cancer diagnostics, and demand for blood tests in breast cancer diagnostics are relatively low in comparison to imaging due to lack of research to back their credibility, accuracy, and in some cases, even affordability.

Breast biopsy for breast cancer diagnostics is anticipated to see a steady rise in popularity over the decade.

How is Demand for Breast Cancer Tests Expected to Grow?

Demand for BRCA tests for breast cancer diagnostics is anticipated to be the most prominent in the marketplace. Demand is driven by most insurers covering the expenses for BRCA tests. Demand for HER 2 tests for breast cancer is expected to be the second-largest in terms of market share.

Demand for CEA tests for breast cancer is anticipated to witness the highest CAGR, followed by ER & PR tests in breast cancer. PCR detection of breast cancer is also a known trend that is expected to see some developments in the near future. Demand for breast cancer diagnostics through PCR test is expected to rise as more research and development aids its popularity.

As research to find better diagnostic solutions increases, so will demand for breast cancer diagnostics at cancer research institutes. Innovative and early diagnostics solutions for breast cancer are constantly being researched on and the trend is expected to be prevalent through the decade.

Avail customized purchase options for your needs

What is the Outlook for Breast Cancer Diagnostics across the Globe?

This research details the global breast cancer diagnostics industry landscape across regions such as North America, Latin America, Europe, APAC, and MEA.

North America is anticipated to account for nearly half of the global breast cancer diagnostics market share in 2021, and this trend is expected to continue throughout the forecast period. Demand in Europe is also expected to be significant over the next ten years.

Demand in the APAC region is expected to be driven by nations such as China and India, where instances of breast cancer are increasing. Demand for breast cancer diagnostics at independent diagnostic laboratories in the APAC region is expected to see an increase as breast cancer diagnosis instruments become more affordable.

Demand for breast cancer diagnosis instruments is also expected to see an increase in MEA owing to development of better healthcare infrastructure and increasing affordability of these instruments.

Breast cancer diagnostics market regional analysis by Fact.MR

Country-wise Analysis

How is the U.S. Breast Cancer Diagnostics Market Shaping Up?

Demand for breast cancer diagnostics in the U.S. is anticipated to increase at a high CAGR owing to rising cases across the nation. Well-established diagnostic infrastructure, technological advancements, increasing healthcare expenditure, and rising awareness about breast cancer are some of the prime factors that are shaping market growth in the country.

Why is Demand for Breast Cancer Diagnostics Increasing across India?

The number of women diagnosed with breast cancer has been increasing in India, and this is common across rural as well as urban areas. Breast cancer accounts for nearly 14% of all cancers found in Indian women.

Rising instances of cancer is driving demand for early breast cancer diagnostics in the nation. Development of affordable and cost-effective diagnostic solutions is a major factor influencing demand in India.

Breast cancer diagnostics market growth through 2031 in India is predicted to rise at a healthy pace.

An Adaptive Approach to Modern-day Research Needs

Category-wise Analysis

What Does This Survey Reveals About Demand for Breast Cancer Diagnostics from Hospital-associated Labs?

Adoption of breast cancer diagnostics at hospital-associated labs is high and accounted for nearly 50% revenue share of the global market in 2020.

Rising hospitalization of patients, increasing instances of breast cancer, and rise in demand for biopsy procedure in breast cancer diagnostics are some of the prime factors driving the hospital-associated labs segment.

COVID-19 Pandemic Evaluation?

Healthcare infrastructure all over the globe took a hit when coronavirus became a global pandemic in the first quarter of 2020. Every nation had to reassess their healthcare strategies, and this resulted in major reforms all across the globe.

With rising prevalence of cancer cases all over the globe, demand from the general population for effective measures to treat and diagnose breast cancer increased, and governments are focusing on extensively providing these solutions in a cost-effective manner. Research on breast cancer diagnostics is expected to be accelerated in the post-pandemic era.

Competitive Landscape

Prime providers of breast cancer diagnostics are striving to come up with diagnostic solutions that offer early detection of breast cancer. Key market players are also investing in the research & development of diagnostic solutions that are fast, accurate, and cost-efficient.

  • Vice President of India, Shri M. Venkaiah Naidu, in September 2021, launched the first-of-its-kind breast cancer helpline, set up by the Ushalakshmi Breast Cancer Foundation. This is a new step for the nation to spread awareness about breast cancer.
  • Elizabeth Hurley, actress and model, launched a cancer support center in London in September 2021, ahead of the cancer awareness month. The support centre was named Future Dreams House.
  • In October 2021, to increase awareness about breast cancer, WellSpan Health and Capital Blue Cross, in collaboration, launched a mobile mammography motor coach, which is in accordance with their goal to increase screening for breast cancer across five countries.

Interested to Procure The Data

Breast Cancer Diagnostics Industry Report Scope

Attribute Details
Forecast Period 2021-2031
Historical Data Available for 2016-2020
Market Analysis Units for Volume and US$ Mn for Value
Key Regions Covered
  • North America
  • Latin America
  • Europe
  • APEJ
  • MEA
Key Countries Covered
  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries
Key Market Segments Covered
  • Test Type
  • End User
  • Region
Key Companies Profiled
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Biocept Inc.
  • Epigenomics AG
  • AstraZeneca plc
  • Myriad Genetics Inc.
  • Quest Diagnostics Incorporated.
Pricing Available upon Request

Key Segments of Breast Cancer Diagnostics Industry Survey

  • By Test Type:

    • CA Tests for Breast Cancer
    • BRCA Test for Breast Cancer
    • ER & PR Test for Breast Cancer
    • CEA Test for Breast Cancer
    • KRAS Mutation Test for Breast Cancer
    • HER 2 Test for Breast Cancer
    • PSA Test for Breast Cancer
    • EGFR Mutation Test for Breast Cancer
    • Immunohistochemistry for Breast Cancer
    • Others
  • By End User:

    • Hospital Associated Labs
    • Independent Diagnostic Laboratories
    • Cancer Research Institutes
    • Others

- FAQs -

BRCA test is the most prominent type of test for breast cancer diagnostics.

Rising healthcare expenditure and increasing awareness about early diagnosis of breast cancer are being witnessed across the landscape.

North America held nearly 45% global market revenue share in 2020.

Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics Inc., and Quest Diagnostics Incorporated are some major players that have been profiled in this survey.

As per Fact.MR’s research, the breast cancer diagnostics industry is predicted to surge at a CAGR of 7% through 2031.

Hospital-associated labs held around 50% share of the global market in 2020.

In 2020, revenue from breast cancer diagnostics amounted to around US$ 4 Bn.

India and China are leading the demand for breast cancer diagnostics in the APAC region.

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Softgel Capsules Market

Softgel Capsules Market has expanding exponentially and is slated to expand at a steady CAGR of 5.5 ...

Medical Marker Bands Market

[170 pages] Global Medical Marker Bands Market research report segmented by Material Type (Platinum-...

Veterinary Progesterone Testing Market

Veterinary Progesterone Testing Market research report covers detailed information on Global Veterin...

Cell Lines Market

Cell lines market is anticipated to showcase moderate growth rate during the forecast period of 2017...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.